Safety, efficacy, and compliance of moderate-to-high dose eptinezumab and erenumab in chronic migraine patients with medication-overuse headache: an updated systematic review and meta-analysis

Fájlok

Journal of Headache and Pain. -26 : 1 (2025), p. 1-11. -(cikkazonosító)99. -J Headache Pain. - 1129-2369. - 1129-2377

open access article
szerző